In this video, I use a genetic algorithm to train an AI to navigate more levels of the world's hardest game. Check out the ...

InvestorAi's AI models empower retail investors with outperforming equity baskets, leveraging proprietary tech. CEO Bruce Keith discusses the company's growth and future plans.

Vgenomics offers RgenX, an AI-powered cloud platform that diagnoses rare genetic diseases and accelerates drug discovery by ...

The number of people living with dementia worldwide was estimated at 57 million in 2021 with nearly 10 million new cases recorded each year. In the U.S., dementia impacts more than 6 million lives, ...

The AI microscopy market is driven by personalized medicine, precision therapy demand, and real-time image advancements.

Key market opportunities in the AI-powered rare disease diagnosis domain include leveraging AI for personalized medicine, ...

As India’s healthcare sector is widening with the rise of patients, the need for effective and quick diagnostics is also ...

For rare diseases, AI-driven repurposing fills a critical gap. With more than 7000 rare diseases and only a small percentage ...

Like humans, artificial intelligence learns by trial and error, but traditionally, it requires humans to set the ball rolling by designing the algorithms and rules that govern the learning process.

Researchers say the study indicates the ability to bring the power of AI and patient-reported outcomes directly into the clinic seamlessly, affordably, and at scale.

Artificial intelligence can be a helpful agriculture tool, but it's not a good idea to be solely dependent on it.